Routine human immunodeficiency virus testing: An economic evaluation of current guidelines

American Journal of Medicine

Volumn 118, Issue 3, 2005, Pages 292-300

  Walensky, Rochelle P ^a,b,c   Weinstein, Milton C ^e   Kimmel, April D ^a,b   Seage III, George R ^d   Losina, Elena ^f   Sax, Paul E ^c   Zhang, Hong ^a,b   Smith, Heather E ^a,b   Freedberg, Kenneth A ^a,b   Paltiel, A David ^g  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD CENTER FOR RISK ANALYSIS   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f BOSTON UNIVERSITY   (United States)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; HIV EIA; HIV AIDS; Screening; Testing

Indexed keywords

ARTICLE; COMPUTER SIMULATION; COST EFFECTIVENESS ANALYSIS; COUNSELING; ECONOMIC EVALUATION; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LIFE EXPECTANCY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST;

EID: 20044376074     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2004.07.055     Document Type: Article

References (68)

1. P.L. Fleming, P.M. Wortley, J.M. Karon, K.M. DeCock, R.S. Janssen Tracking the HIV epidemic current issues, future challenges Am J Public Health. 90 2000 1037 1041
2. CDC Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings MMWR Recomm Rep. 42 1993 1 6
3. CDC Revised guidelines for HIV counseling, testing, and referral MMWR Recomm Rep. 50 2001 1 57
4. R.S. Janssen, M.E. St Louis, G.A. Satten HIV infection among patients in U.S. acute care hospitals. Strategies for the counseling and testing of the hospital patients. The Hospital HIV Surveillance Group N Engl J Med. 327 1992 445 452
5. M.E. St Louis, K.J. Rauch, L.R. Petersen, J.E. Anderson, C.A. Schable, T.J. Dondero The Sentinel Hospital Surveillance Group Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States N Engl J Med. 323 1990 213 218
6. M.A. Goggin, A.J. Davidson, S.V. Cantril, L.K. O'Keefe, J.M. Douglas The extent of undiagnosed HIV infection among emergency department patients results of a blinded seroprevalence survey and a pilot HIV testing program J Emerg Med. 19 2000 13 19
7. K.J. Rhee, T.E. Albertson, K.W. Kizer, M.J. Burns, M.J. Hughes, M.S. Ascher A comparison of HIV-1, HBV, and HTLV-I/II seroprevalence rates of injured patients admitted through California emergency departments Ann Emerg Med. 21 1992 397 401
8. R.P. Walensky, E. Losina, K.A. Steger-Craven, K.A. Freedberg Identifying undiagnosed human immunodeficiency virus the yield of routine, voluntary inpatient testing Arch Intern Med. 162 2002 887 892
9. J.M. Pincus, S.S. Crosby, E. Losina, E.R. King, C. LaBelle, K.A. Freedberg Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center Clin Infect Dis. 37 2003 1699 1704
10. C. del Rio, C.F. Paredas, W. Duffus Routinely recommended HIV testing at an urban urgent-care clinic--Atlanta, Georgia, 2000 MMWR Morb Mortal Wkly Rep. 50 2001 538 541
11. G.D. Kelen, J.B. Shahan, T.C. Quinn Emergency department-based HIV screening and counseling experience with rapid and standard serologic testing Ann Emerg Med. 33 1999 147 155
12. N.R. Glick, A. Silva, L. Zun, S. Whitman HIV testing in a resource-poor urban emergency department AIDS Educ Prev. 16 2004 126 136
13. K.L. Irwin, R.O. Valdiserri, S.D. Holmberg The acceptability of voluntary HIV antibody testing in the United States a decade of lessons learned AIDS. 10 1996 1707 1717
14. K.A. Freedberg, E. Losina, M.C. Weinstein The cost effectiveness of combination antiretroviral therapy for HIV disease N Engl J Med. 344 2001 824 831
15. K.A. Freedberg, J.A. Scharfstein, G.R. Seage III The cost-effectiveness of preventing AIDS-related opportunistic infections JAMA. 279 1998 130 136
16. M.C. Weinstein, S.J. Goldie, E. Losina Use of genotypic resistance testing to guide HIV therapy clinical impact and cost-effectiveness Ann Intern Med. 134 2001 440 450
17. Multicenter AIDS Cohort Study (MACS) Public Dataset Release PO4 1995 National Technical Information Service Springfield, Virginia
18. C. Enger, N. Graham, Y. Peng Survival from early, intermediate, and late stages of HIV infection JAMA. 275 1996 1329 1334
19. J.W. Mellors, A. Munoz, J.V. Giorgi Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection Ann Intern Med. 126 1997 946 954
20. J.H. Samet, K.A. Freedberg, J.B. Savetsky, L.M. Sullivan, M.D. Stein Understanding delay to medical care for HIV infection the long-term non-presenter AIDS. 15 2001 77 85
21. The Panel on Clinical Practices for Treatment of HIV Infection convened by the Department of Health and Human Services (DHHS) and the Henry J. Kaiser Family Foundation Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents 2003 November 10, Available at http://aidsinfo.nih.gov
22. G. Carcelain, C. Blanc, J. Leibowitch T cell changes after combined nucleoside analogue therapy in HIV primary infection AIDS. 13 1999 1077 1081
23. G.R. Kaufmann, J.J. Zaunders, P. Cunningham Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection AIDS. 14 2000 2643 2651
24. U. Malhotra, M.M. Berrey, Y. Huang Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection J Infect Dis. 181 2000 121 131
25. R.P. Walensky, S.J. Goldie, P.E. Sax Treatment for primary HIV infection projecting outcomes of immediate, interrupted, or delayed therapy J Acquir Immune Defic Syndr. 31 2002 27 37
26. M. Dybul, R. Bolan, D. Condoluci Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings J Infect Dis. 185 2002 1818 1821
27. J.E. Sackoff, S.S. Shin Trends in immunologic and clinical status of newly diagnosed HIV-positive patients initiating care in the HAART era J Acquir Immune Defic Syndr. 28 2001 270 272
28. A. Roome, J. Hadler, G. Birkhead HIV testing among pregnant women--United States and Canada, 1998-2001 MMWR Morb Mortal Wkly Rep. 51 2002 1013 1016
29. R.P. Walensky, E. Losina, P.R. Skolnik Voluntary HIV testing as part of routine medical care--Massachusetts, 2002 MMWR Morb Mortal Wkly Rep. 53 2004 523 526
30. E.M. Stringer, J.S. Stringer, S.P. Cliver, R.L. Goldenberg, A.R. Goepfert Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates MMWR Morb Mortal Wkly Rep. 50 2001 1054 1058
31. Update HIV counseling and testing using rapid tests--United States, 1995 MMWR Morb Mortal Wkly Rep. 47 1998 211 215
32. CDC HIV Counseling and Testing in Publicly Funded Sites 1995 Summary Report 1997 U.S. Department of Health and Human Services Atlanta, Georgia
33. M. Moore, A.R. Gerber, C.H. Campbell Jr, B.A. Dillon, G.R. West, R.O. Valdiserri A study of clients returning for counseling after HIV testing implications for improving rates of return Pub Health Rep. 108 1993 12 18
34. R.A. Bell, S.R. Truax, J.D. Ruiz, R.K. Sun, F. Molitor Predictors of failure to return for HIV test result and counseling by test site type AIDS Educ Prev. 11 1999 1 13
35. S. Staszewski, J. Morales-Ramirez, K.T. Tashima Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team N Engl J Med. 341 1999 1865 1873
36. S.M. Hammer, K.E. Squires, M.D. Hughes AIDS Clinical Trials Group 320 Study Team A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less N Engl J Med. 337 1997 725 733
37. J.D. Baxter, D.L. Mayers, D.N. Wentworth CPCRA 046 Study Team for the Terry Beirn Community Programs for Clinical Research on AIDS A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy AIDS. 14 2000 F83 F93
38. E. Mylonakis Laboratory testing for infection with the human immunodeficiency virus established and novel approaches Am J Med. 109 2000 568 576
39. B. Varghese, T.A. Peterman, D.R. Holtgrave Cost-effectiveness of counseling and testing and partner notification a decision analysis AIDS. 13 1999 1745 1751
40. P.G. Farnham, R.D. Gorsky, D.R. Holtgrave, W.K. Jones, M.E. Guinan Counseling and testing for HIV prevention costs, effects, and cost-effectiveness of more rapid screening tests Public Health Rep. 111 1996 44 53
41. D.U. Ekwueme, S.D. Pinkerton, D.R. Holtgrave, B.M. Branson Cost comparison of three HIV counseling and testing technologies Am J Prev Med. 25 2003 112 121
42. Drug Topics Red Book 2001 Medical Economics Montvale, New Jersey
43. Health Care Financing Administration (HCFA) of the Department of Health and Human Services (DHHS) Clinical Diagnostic Laboratory Fee Schedule (CLAB) 2001 Available at: www.cms.hhs.gov/providers/pufdownload/default.asp#labfree Accessed September 22, 2003
44. J.E. Kaplan, H. Masur, K.K. Holmes Public Health Service and the Infectious Diseases Society of America Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S MMWR Recomm Rep. 51 2002 1 52
45. Statistical Abstract of the United States 1998 118th ed. 1998 Bureau of the Census Washington, D.C
46. Statistics for U.S. Hospital Stays, Diagnosis Related Groups (DRGs), Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS). Agency for Healthcare Research and Quality. Rockville, Maryland. Available at: http://hcup.ahrq.gov/HCUPnet.asp Accessed December 23, 2003
47. E.S. Daar, S. Little, J. Pitt Los Angeles County Primary HIV Infection Recruitment Network Diagnosis of primary HIV-1 infection Ann Intern Med. 134 2001 25 29
48. F.M. Hecht, M.P. Busch, B. Rawal Use of laboratory tests and clinical symptoms for identification of primary HIV infection AIDS. 16 2002 1119 1129
49. AIDS Cost and Services Utilization Survey Public Use Tapes 4 and 5. No. PB94189891 1994 National Technical Information Service Springfield, Virginia
50. S.A. Finkler The distinction between cost and charges Ann Intern Med. 96 1982 102 109
51. M.R. Gold, J.E. Siegel, L.B. Russell, M.C. Weinstein Cost Effectiveness in Health and Medicine 1996 Oxford University Press New York, New York
52. F.J. Palella Jr, K.M. Delaney, A.C. Moorman Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection N Engl J Med. 338 1998 853 860
53. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults MMWR Recomm Rep. 41 1992 961 962
54. CDC HIV/AIDS Surv Rep. 11 1999 1 44
55. L.C. Immergluck, W.L. Cull, A. Schwartz, A.S. Elstein Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago Pediatrics. 105 2000 E54
56. N.L. McKay, K.M. Phillips An economic evaluation of mandatory premarital testing for HIV Inquiry. 28 1991 236 248
57. D.K. Owens, R.F. Nease Jr, R.A. Harris Cost-effectiveness of HIV screening in acute care settings Arch Intern Med. 156 1996 394 404
58. P. Lurie, A.L. Avins, K.A. Phillips, J.G. Kahn, R.A. Lowe, D. Ciccarone The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection JAMA. 272 1994 1832 1838
59. The cost-effectiveness of screening for type 2 diabetes CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention JAMA. 280 1998 1757 1763
60. B. Littenberg, A.M. Garber, H.C. Sox Jr. Screening for hypertension Ann Intern Med. 112 1990 192 202
61. A.L. Frazier, G.A. Colditz, C.S. Fuchs, K.M. Kuntz Cost-effectiveness of screening for colorectal cancer in the general population JAMA. 284 2000 1954 1961
62. U.S. Preventive Services Task Force Guide to Clinical Preventive Services 2nd ed. 1996 Williams and Wilkins Baltimore, Maryland
63. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group The NIMH Multisite HIV Prevention Trial reducing HIV sexual risk behavior Science. 280 1998 1889 1894
64. M.L. Kamb, M. Fishbein, J.M. Douglas Jr Project RESPECT Study Group Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases a randomized controlled trial JAMA. 280 1998 1161 1167
65. D. Gibson Effectiveness of brief counseling in reducing HIV risk behavior in injecting drug users final results of randomized trials of counseling with and without HIV testing AIDS Behav. 3 1999 3 12
66. A.S. Morrison Screening in Chronic Disease 2nd ed. 1992 Oxford University Press New York, New York
67. Cancer Facts and Figures, 2002 Vol. 2003 2002 American Cancer Society Atlanta, Georgia
68. Advancing HIV prevention new strategies for a changing epidemic--United States, 2003 MMWR Morb Mortal Wkly Rep. 52 2003 329 332